Phesgo and Tecentriq Performance and Approvals slide image

Phesgo and Tecentriq Performance and Approvals

Diagnostics key launches 2023 Roche Area Product CCM Vertical Description Modular transportation system, integrated into the existing cobas connection modules, allowing for overhead sample transportation over different work areas or different floors enabling effective use of lab space Markets Status Global Core Lab cobas pro integrated solutions Scalable and modular serum work area analyzer for mid to high volume clinical chemistry and immunochemistry testing China Instruments Automation cobas pure integrated solutions Serum work area analyzer for low to mid volume clinical chemistry and immunochemistry testing on a footprint of two square meters China Molecular Lab LightCycler Pro Point of Care cobas pulse Pathology Lab IDH1 R132H (IDH Glioma) Flexible real-time PCR instrument with dual IVD and research mode as well as enhanced system features Handheld device combining professional glucose meter and a digital platform to host digital clinical decision support applications (from Roche and third parties) Neuropathology Immunohistochemistry (IHC) solution supporting the detection of tumor cells with the IDH1 R132H mutation aiding pathologists to render a diagnosis of gliomas Anti-HEV IgM: Immunoassay aiding in the diagnosis of acute HEV infection in clinical settings; Anti-HEV Anti-HEV IgG and Anti-HEV IgG: Immunoassay aiding in the detection of a recent or past HEV infection and enabling accurate IgM seroprevalence determinations. The two assays expand the hepatitis panel (HAV, HBV, HCV, HEV) on the same analytical platform US & CE US US CE Tests Core Lab HBeAg Quant Immunoassay aiding in diagnosis, monitoring and predicting treatment response for patients with hepatitis B viral infection CE IL-6 Neonatal sepsis (claim Only immunoassay available on the market with dedicated claim and supporting evidence aiding in extension) diagnosis of sepsis in neonates, with potential to reduce newborn mortality RUO Amyloid Plasma Assays (pTau181 & ApoE4) RUO Digital Pathology Algorithm: PD-L1 SP142 navify Algorithm Suite Menu for navify Algorithm Suite Pathology Lab Digital Solutions Lab Insights cobas infinity lab 3.05 navify Marketplace navify Sample Tracking CE Two qualitative immunoassays measuring the phosphorylated Tau 181 protein and apolipoprotein E4 in human plasma for research use only US Digital pathology algorithm aiding pathologists in scoring PD-L1 (SP142) breast samples, ensuring a standardized approach and an adjunctive tool to augment diagnostic confidence for research use only Digital solution providing access to an open library of certified IVD-based clinical algorithms Certified clinical algorithms for oncology applications such as colon and liver cancers Next-generation lab middleware enabling ecosystem of cloud-based solutions for quality control and instrument maintenance Global Selected markets1 Selected markets1 Global Digital marketplace offering lab customers full range of innovative applications (from Roche and third parties) Selected marketsĀ¹ Open digital solution offering sample tracking beyond the lab setting (from IVD-sample creation to lab Selected markets1 reception) to improve testing traceability and quality 1 Selected markets: 14 countries with first releases // CE: European conformity; RUO: Research use only; PCR: Polymerase chain reaction; IVD: In vitro diagnostic; IDH: Isocitrate dehydrogenase; HEV: Hepatitis E virus; HAV: Hepatitis A virus; HBV: Hepatitis B virus; HCV: Hepatitis C virus 42 42
View entire presentation